Haifeng Eishingdrelo
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$2.5MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 31, 2023 | NIH | SBIR Phase I New 5HT2AR Target Identification and Assay Development for Discovering Psychoplastogenic Compounds | $319K | BIOINVENU CORPORATION |
| Sep 30, 2019 | NIH | SBIR Phase I Screen molecules modulating MOR trafficking with a newly developed MOR/14-3-3 bioassay. | $321K | BIOINVENU CORPORATION |
| Mar 13, 2018 | NIH | SBIR Phase II Novel tools for investigating GPCR-mediated 14-3-3 signaling pathway | $767K | BIOINVENU CORPORATION |
| Mar 27, 2017 | NIH | SBIR Phase II Novel tools for investigating GPCR-mediated 14-3-3 signaling pathway | $773K | BIOINVENU CORPORATION |
| Apr 15, 2016 | NIH | SBIR Phase I Novel tools for investigating GPCR-mediated 14-3-3 signaling pathway | $331K | BIOINVENU CORPORATION |
Peer ranks
Federal funding#763
Awards as PI#417
Patents#273
Companies
- BIOINVENU CORPORATIONLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.